These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 35415942)

  • 1. Effect of Glut-1 and HIF-1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway.
    Bao YY; Zhong JT; Shen LF; Dai LB; Zhou SH; Fan J; Yao HT; Lu ZJ
    J Cell Mol Med; 2022 May; 26(10):2881-2894. PubMed ID: 35415942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
    Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
    World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo.
    Bao YY; Zhou SH; Lu ZJ; Fan J; Huang YP
    Oncol Rep; 2015 Oct; 34(4):1805-14. PubMed ID: 26238658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo.
    Luo XM; Xu B; Zhou ML; Bao YY; Zhou SH; Fan J; Lu ZJ
    PLoS One; 2015; 10(11):e0143306. PubMed ID: 26600164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of 2-phenylethyl-beta-glucopyranoside isolated from Huaizhong No. 1 Rehmannia glutinosa on hypoxic pulmonary hypertension by regulating PI3K/Akt/m TOR/HIF-1α pathway].
    Zeng MN; Zhang YH; Guo PL; Zhang ZY; Liu YL; Wang R; Tie QM; Wang YY; Chang FZ; Feng WS; Zheng XK
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3857-3867. PubMed ID: 39099359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a GLUT-1 and HIF-1α gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.
    Lu ZJ; Yu Q; Zhou SH; Fan J; Shen LF; Bao YY; Wu TT; Zhou ML; Huang YP
    Cancer Manag Res; 2019; 11():2087-2096. PubMed ID: 30881132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
    Yeh YH; Hsiao HF; Yeh YC; Chen TW; Li TK
    J Exp Clin Cancer Res; 2018 Mar; 37(1):70. PubMed ID: 29587825
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
    Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
    [No Abstract]   [Full Text] [Related]  

  • 12. Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway.
    Yang X; Gao M; Miao M; Jiang C; Zhang D; Yin Z; Ni Y; Chen J; Zhang J
    J Pharm Pharmacol; 2021 Mar; 73(2):263-271. PubMed ID: 33793802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
    Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K
    Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
    Sudhagar S; Sathya S; Lakshmi BS
    Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.
    Jampasri S; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways.
    Zhao ZX; Li S; Liu LX
    World J Gastroenterol; 2024 Jun; 30(21):2793-2816. PubMed ID: 38899332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter-1 and hypoxia-inducible-factor-1α and the phosphoinositide 3-kinase/protein kinase B pathway.
    Zhao K; Yang SY; Zhou SH; Dong MJ; Bao YY; Yao HT
    Oncol Lett; 2014 Apr; 7(4):984-990. PubMed ID: 24944654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
    Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.